阿齐思罗米在上呼吸道感染 (URTI) 管理中的作用:印度现实生活经验
Mathew Dominic1, Rakesh Srivastava2, Kshitij Shah3
1Medical Trust Hospital, Ernakulam, 682016, Kerala, India.
Infection and drug resistance
|February 3, 2025
概括
在印度的一项实验研究中,阿齐思罗米显著改善了上呼吸道感染 (URTI) 的症状和迹象. 该抗生素的副作用发生率很低,证实了其在URTI治疗中的有效性.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 上呼吸道感染 (URTI) 是一个主要的全球健康问题.
- 阿齐思罗米是URTI的广泛使用的抗生素,因为它具有广泛的活性和有利的药理动力学特征.
研究的目的:
- 评估阿齐思罗米在治疗URTI中的实际有效性和安全性.
- 评估阿齐思罗米对URTI症状,临床症状和患者报告结果的影响.
主要方法:
- 这是一项多中心,回顾性,观察性研究,涉及印度184家ENT诊所的884名成年患者.
- 患者接受了500毫克阿兹罗米辛5天;分析了症状,临床征兆和缺勤数据.
- 统计分析包括配对的t测试和McNemar-Bowker测试,以评估与基线的变化.
主要成果:
- 观察到URTI症状显著减少,如喉疼痛 (95.8%至10.4%) 和发烧 (97.4%消失).
- 临床症状,如喉和桃体红斑,以及桃体排泄物显著改善.
- 工作缺勤率从47.9%大幅下降到1%; 97.2%的患者报告总体状况有了显著改善,不良事件率为2.37%.
结论:
- 阿齐思罗米在现实环境中有效改善URTI的临床表现.
- 这项研究证实了阿齐思罗米在治疗URTI症状和症状方面的显著疗效.
- 治疗URTI的阿兹罗密治疗与不良事件的发病率较低有关.
相关概念视频
01:30Acute Pharyngitis
379
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
379
01:26Tonsillitis II: Management
102
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
102
01:16Drugs Used in Upper Respiratory Disorders: Overview
177
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
177
01:28Pneumonia IV: Management
296
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296
01:23Chronic Pharyngitis
989
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
989
01:17Drugs Used in Lower Respiratory Disorders: Overview
344
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
344